EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cholangiolocellular Component Predicts a Biologically Distinct Subgroup of Mass‐Forming Intrahepatic Cholangiocarcinoma

Naoto Kubota iD, Ken Yamazaki, Yasuhito Arai, Minoru Esaki, Nobuyoshi Hiraoka iD, Hirofumi Shirakawa, Moriaki Tomikawa, Tatsuhiro Shibata iD, Michiie Sakamoto, Hidenori Ojima

Cancer Science · 2026-05 · 117 (5) · 1510-1523

DOI: 10.1111/cas.70348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, online erschienen am 02.03.2026. Verfasst von Naoto Kubota und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathology, Research Institute, Tochigi Cancer Center, Tochigi, Japan. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cholangiolocellular carcinoma (CLC) is a histopathological variant of primary liver tumor with unique morphologies, and intrahepatic cholangiocarcinomas (iCCAs) frequently contain a CLC component; however, the biological characteristics of iCCA with CLC remain undescribed. In this study, 36 mass‐forming iCCAs (MF‐iCCAs), histologically small‐duct type iCCA, were classified into CLC(+) iCCAs and CLC(−) iCCAs by the presence/absence of the CLC component. Two genetic subgroups were generated using highly expressed genes in CLC(+) iCCA and CLC(−) iCCA. As the results of clinicopathological and genetic analyses, CLC(+) iCCA had better overall survival and upregulation of stromal‐ and oxidation‐related genes, whereas CLC(−) iCCA showed upregulation of proliferation‐ and hypoxia‐related genes. Two genetic subgroups of iCCA were identified: iCCA‐G1, which was related to CLC, and iCCA‐G2, which was unrelated to CLC. iCCA‐G1 comprised all 14 CLC(+) iCCAs [CLC(+)G1] and 7 of 19 CLC(−) iCCAs [CLC(−)G1], whereas iCCA‐G2 was composed only of CLC(−) iCCAs [CLC(−)G2]. CLC(+)G1 and CLC(−)G1 exhibited similar patterns of somatic gene alterations compared with CLC(−)G2. Angiogenesis‐related genes were upregulated in CLC(+)G1, and the number of tumor vessels was larger in CLC(+)G1, followed by CLC(−)G1, compared with CLC(−)G2. Further, SPP1 (encoding osteopontin) was identified as a highly expressed angiogenesis‐related gene in CLC(+) iCCA. Immunohistochemical expression of osteopontin was high in CLC(+) iCCA, showing apical and/or cytoplasmic expression patterns, which should facilitate the histopathological classification of iCCA‐G1 and iCCA‐G2. CLC component is useful for predicting a distinct genetic subgroup of MF‐iCCA with better prognosis, high angiogenesis, and different gene alteration patterns, indicating different carcinogenic pathways of MF‐iCCA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaBile Duct NeoplasmsHumansFemaleMaleMiddle AgedAgedPrognosisGene Expression Regulation, NeoplasticOsteopontinBile Ducts, IntrahepaticBiomarkers, Tumor

Stichwörter der Autor:innen

angiogenesischolangiolocellular carcinomaintrahepatic cholangiocarcinomamass‐forming typeosteopontin

Substanzen

OsteopontinBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Molecular Pathology, Research Institute, Tochigi Cancer Center, Tochigi, Japan.
  • Department of Pathology, Tochigi Cancer Center, Tochigi, Japan.
  • Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
  • Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
  • Hepatobiliary Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
  • Division of Molecular Pathology, National Cancer Centre Research Institute, Tokyo, Japan.

ORCID-Profile: Naoto Kubota, Nobuyoshi Hiraoka, Tatsuhiro Shibata

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Kubota, N., Yamazaki, K., Arai, Y., Esaki, M., Hiraoka, N., Shirakawa, H., Tomikawa, M., Shibata, T., Sakamoto, M., & Ojima, H. (2026). Cholangiolocellular Component Predicts a Biologically Distinct Subgroup of Mass‐Forming Intrahepatic Cholangiocarcinoma. Cancer Science, 117(5), 1510-1523. https://doi.org/10.1111/cas.70348

Vancouver

Kubota N, Yamazaki K, Arai Y, Esaki M, Hiraoka N, Shirakawa H, et al. Cholangiolocellular Component Predicts a Biologically Distinct Subgroup of Mass‐Forming Intrahepatic Cholangiocarcinoma. Cancer Science. 2026;117(5):1510-1523. doi:10.1111/cas.70348

BibTeX
@article{Kubota2026,
  author = {Kubota, Naoto and Yamazaki, Ken and Arai, Yasuhito and Esaki, Minoru and Hiraoka, Nobuyoshi and Shirakawa, Hirofumi and Tomikawa, Moriaki and Shibata, Tatsuhiro and Sakamoto, Michiie and Ojima, Hidenori},
  title = {Cholangiolocellular Component Predicts a Biologically Distinct Subgroup of Mass‐Forming Intrahepatic Cholangiocarcinoma},
  journal = {Cancer Science},
  year = {2026},
  volume = {117},
  number = {5},
  pages = {1510--1523},
  doi = {10.1111/cas.70348}
}
Kostenlos starten →